(2R,3S)-1-((R)-2-((1-Aminoisoquinolin-6-yl)amino)-2-(4-fluoro-3-methoxyphenyl)acetyl)-2-(2-(ethylsulfonyl)phenyl)pyrrolidine-3-carboxylic acid

Catalog No. :
ACJASX229
CAS No. :
900173-62-8
Molecular Formula :
C31H31FN4O6S
Molecular Weight :
606.68

IUPAC Name:(2R,3S)-1-((R)-2-((1-aminoisoquinolin-6-yl)amino)-2-(4-fluoro-3-methoxyphenyl)acetyl)-2-(2-(ethylsulfonyl)phenyl)pyrrolidine-3-carboxylic acid

(2R,3S)-1-((R)-2-((1-Aminoisoquinolin-6-yl)amino)-2-(4-fluoro-3-methoxyphenyl)acetyl)-2-(2-(ethylsulfonyl)phenyl)pyrrolidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S)-1-((R)-2-((1-Aminoisoquinolin-6-yl)amino)-2-(4-fluoro-3-methoxyphenyl)acetyl)-2-(2-(ethylsulfonyl)phenyl)pyrrolidine-3-carboxylic acid
IUPAC Name(2R,3S)-1-((R)-2-((1-aminoisoquinolin-6-yl)amino)-2-(4-fluoro-3-methoxyphenyl)acetyl)-2-(2-(ethylsulfonyl)phenyl)pyrrolidine-3-carboxylic acid
Molecular FormulaC31H31FN4O6S
Molecular Weight606.68
SMILESC([C@H](NC1=CC2=C(C=C1)C(N)=NC=C2)C3=CC(OC)=C(F)C=C3)(=O)N4[C@H]([C@@H](C(O)=O)CC4)C5=C(S(CC)(=O)=O)C=CC=C5
InChI KeyIZSJEKWHRIABKB-LBNPDIFZSA-N
SynonymIZSJEKWHRIABKB-LBNPDIFZSA-N;3-Pyrrolidinecarboxylic acid, 1-[(2R)-2-[(1-amino-6-isoquinolinyl)amino]-2-(4-fluoro-3-methoxyphenyl)acetyl]-2-[2-(ethylsulfonyl)phenyl]-, (2R,3S)-
CAS No.900173-62-8

Synthetic Route by SureRoute

1. ACJASX229 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJASX229 route product structure diagram
    ACJASX229900173-62-8
Inquiry

2. ACJASX229 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJASX229 route product structure diagram
    ACJASX229900173-62-8
Inquiry

Comments (0)